Thursday, Nov. 10
Thursday, Nov. 10, 2022 | 12-1 p.m. | Room 156, BCEC
Immunogenomic determinants of response and resistance to PD-1 blockade
Kellie Smith, PhD, Johns Hopkins University
Multiomic Profiling of Immune Diversity, Cell by Cell
Jose Jacob, MS, 10x Genomics
Thursday, Nov. 10, 2022 | 11:40 a.m.-1:10 p.m. | Room 157, BCEC
Expanding the Power of Spatial Biology
Hear from thought leaders in Spatial Biology at NanoString’s Spatial Symposium. This session will showcase the most comprehensive spatial biology solutions from samples to insight. Leverage the leading high-plex, multiomics spatial platforms from single cell resolution to whole transcriptome and spatial proteome for biomarker discovery and pathway analysis and unlock the tumor microenvironment in FFPE tissues. All spatial data can be analyzed, stored and shared using a cloud-based, secure and scalable informatic solution, AtoMx Spatial Informatics Platform.
Learn more about the range of spatial biology solutions offered by NanoString and a roadmap for the future development of the AtoMx Spatial Informatics Platform, CosMx Spatial Molecular Imager, and GeoMx Digital Spatial Profiler.
Pelotonia Institute for Immuno-Oncology OSU Comprehensive Cancer Center
Thursday, Nov. 10, 2022 | 12-1 p.m. | Exhibit Hall Stage, BCEC
Sex Bias and Cancer Immunotherapy
This symposium will address the striking sex-dependent discrepancies in incidence, progression, response to treatment, and survival outcomes for patients with cancers stemming from non-reproductive organs, such as bladder, prostate, and brain cancer. Sex bias in cancer and response to immunotherapy are phenomena that have puzzled the scientific community for decades. Recently, our understanding about the role of sex in tumor immunology has advanced, providing opportunities to improve targeted therapies. With this symposium, we will present recent updates in the field of immuno-oncology, immunotherapy, and disease outcomes within the context of sex-based disease discrepancies. This symposium will give attendees a unique opportunity to learn from top researchers studying the intersection between sex, tumor immunology, and translational therapeutics.
Thursday, Nov. 10, 2022 | 7:30-9 p.m. | Room 156, BCEC
Supercharging Spatial Signature Development: Predictive Biomarkers for the Ever-Changing Immunotherapy Landscape
The emergence of new immunotherapies as the first line of treatment for cancer, necessitates the development of clinically useful biomarkers to select responders that will be critical for the advancement of such treatments. Join us to learn about spatial signatures, biomarkers based on spatial relationships and protein co-expression on specific cellular subsets that are assessed within the context of the tumor immune microenvironment (TiME), which have demonstrated higher accuracy in predicting response to immunotherapies. Learn from speakers about Akoya’s new multiplex panels based on novel protein chemistry that can accelerate the development of spatial signatures, simplifying the pathway to improved stratification to immunotherapy response.
Clinical Care Options
Thursday, Nov. 10, 2022 | 7:30-9 p.m. | Room 157, BCEC
Lung Cancer Immunotherapy: Improving Patient Outcomes Across the Disease Continuum
Join us in person or online for this live CME symposium at SITC 2022 Annual Meeting to hear expert insights on best practices for the use of immune checkpoint inhibitor therapy for patients with NSCLC. Click here to view this symposia.
Discovery Life Sciences
Thursday, Nov. 10, 2022 | 7:30-9 p.m. | Room 206, BCEC
Multi-Omic Analysis of Matched Human Biospecimens to Inform Drug and Biomarker Development